Fundraising Fox
Global Health Investment Corporation
Impact investorNew York · Seed–Series B · 5 people tracked
Also known as GHIC ADVISORS, LLC
Find your way into Global Health Investment Corporation
Sign up to see every warm intro you have to Global Health Investment Corporation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Global Health Investment Corporation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
GHIC is a nonprofit impact investor that has funded global health innovation for over a decade. It targets life sciences and healthcare technology companies whose products can improve global public health, advance health equity, and generate sustainable returns. Its investments focus on global health security and urgent challenges such as infectious disease and maternal and child health. Its namesake $108 million Global Health Investment Fund backed twelve companies developing diagnostics, devices, vaccines, and therapeutics for diseases like HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA, GHIC uses venture capital to support technologies that respond to or prevent public health emergencies such as pandemics.
Source: firm website, verified Sep 29, 2026.
Team · 5 people
from the firm's website & curated & public directories
What they invest in
from 22 of 32 portfolio companiesBiotech ×18Healthtech ×16Medical Devices ×11AI & Machine Learning ×5Deep Tech ×5Digital Health ×5Advanced Manufacturing ×3Circular Economy ×1
HQs:United States×13Australia×1United Kingdom×1
Who they back
founder profiles across 12 portfolio companiesFounding team size:solo founder×62 founders×23 founders×34+ founders×1
Where their founders studiedfrom 15 founders with education data
Cornell ×2Cornell Johnson Graduate School of Management ×2Massachusetts Institute of Technology ×2Stanford University ×2Stony Brook University ×2University of California, Berkeley ×2
What their founders studiedfrom 16 founders with field-of-study data
Engineering ×10Life Sciences ×6Business & Management ×3
Investments · 32 tracked
founders shown can be your intro pathBy year:2026 · 22025 · 13 dated
Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ajay Shah(Founder)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)
BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in
Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesDolby Family Ventures+6 more
Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases.
BiotechHealthtechMedical DevicesSomerset, US
Young Ho Choi(Executive Officer, Director)
BoardTom Sabourin(Director)Seung Jae Baek(Director)Sang Hoon Kang(Director)
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)
Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstIaso VenturesLingotto+6 more
Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings.
HealthtechMedical Devices
Co-investorsAstiaAvestria VenturesGlobal Health Investment Fund
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina Smolke(Founder)inKristy Hawkins(Founder)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
BoardRam Shriram(Director)
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcIn-Q-TelLam CapitalSherpalo VenturesWestern Technology Investment
Apriori Bio applies AI/ML combined with biological insights to predict how viruses evolve and to design vaccines, assessing their expected performance before clinical trials.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsFlagship Pioneering
Atomo Diagnostics develops diagnostic ecosystems and mobile applications for point-of-care testing, including whole-blood cassettes and reader devices compatible with smartphones for remote diagnostics.
BiotechDeep TechDigital HealthHealthtechMedical Devices
John Kelly(Founder and CEO)in
Co-investorsSydney AngelsTransition Level Investments
Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.
BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US
Jared Tangney(Co-founder)inRich Yang(Co-founder)inEdward Kliphuis(Director)
BoardDaniel Bradbury(Director)inLana Ghanem(Director)
Co-investorsAlpha Wave GlobalRiverVest Venture PartnersAble PartnersAphelion CapitalAverin CapitalBeyond Capital+7 more
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosCivilization Ventures Management, LlcIn-Q-TelSherpalo VenturesViking Global Investors
Centivax is a biotechnology company developing broad-spectrum vaccines, including a universal influenza vaccine.
BiotechHealthtech
Jacob Glanville(Founder)inStephanie Wisner(Founder)in
Co-investorsAmplify PartnersBold Capital PartnersFuture VenturesKendall Capital PartnersNFX
Endpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.
BiotechHealthtechSan Francisco, US
Diego Rey(Founder/CSO)inJeff Osborn(Founder)inJason Springs(Founder)inLeonardo Teixeira(Founder)in
Co-investorsAlix VenturesKnockout CapitalY CombinatorAME Cloud VenturesBoom CapitalBoom Capital Ventures+6 more
Genedrive Diagnostics develops and commercialises a rapid point-of-care pharmacogenetic testing platform that detects genetic variants to guide personalised medicine decisions in emergency healthcare.
BiotechDigital HealthMedical Devices
Co-investorsSeneca Partners
HealthtechReno, US
Tsontcho Ianchulev(Executive Officer, Director)Charles Warden(Director)Brian Walsh(Executive Officer, Director)Bruce J. Brumfield, Jr.(Director)Glenn Rockman(Director)inJim Mazzo(Director)
Co-investorsVisionary VenturesGlobal Health Investment Fund
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
David Michael Salter(Executive Officer, Director)Mike Salter(CEO/President)inEugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)
Co-investorsArboretum VenturesBaird CapitalLYZZ Capital
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups.
BiotechHealthtechMedical DevicesAtlanta, US
Mark Prausnitz(Director)inHenry Sebastien(Executive Vice President, Head of Technical Operations)Devin McAllister(Executive Vice President, Chief Technology Officer)inIdean Marvasty(Chief Financial Officer)Steve Damon(Chief Executive Officer)in
BoardBas Van Buijtenen(Director)
Co-investorsGRA VentureJ2 VenturesGlobal Health Security
Monod Bio is a University of Washington spin-out that uses AI-powered de novo protein design to develop research-use-only tools and in vitro diagnostics.
AI & Machine LearningBiotechMedical DevicesSeattle, US
Daniel Adriano Silva Manzano(Executive Officer, Director)Alfredo Quijano Rubio(Co-Founder, CSO, Board Observer)inDaniel Silva Manzano(Co-Founder, CEO, Board Member)Greg Tibbitts(Fractional CFO)Dave Johnson(Director)David Shoultz(Executive Officer, Director)
Co-investorsPack Ventures
PHC Global builds AI-driven systems that fuse distributed biological data streams (wastewater, clinical, syndromic, environmental) with contextual intelligence to detect anomalies and produce decision-ready biological threat intelligence.
AI & Machine LearningDefense TechHealthtech
Charity Dean(Founder)
Co-investorsVenrock
Prenosis develops AI-powered precision medicine diagnostics for acute care, built on its Immunix platform and a biobank of clinical data for infection.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsPACE Healthcare Capital
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)William S. Marth, RPh., MBA(President & CEO)
BoardRobert Nelsen(Chairman, Resilience; Founder, ARCH)
Co-investors8VCARCH Venture PartnersCatalio Capital Management, LPGV (Google Ventures)Koch Disruptive TechnologiesLux Capital+14 more
Serum Institute of India (SII) develops and manufactures vaccines, including candidates for tuberculosis and Bundibugyo ebolavirus, working with partners such as the Oxford Vaccine Group and the Gates Medical Research Institute.
BiotechHealthtech
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections.
BiotechDeep TechMedical Devices
Rachel Sha(CEO)in
Co-investorsRA CapitalThe Engine VenturesUlu Ventures
Biomanufacturing technology platform and CDMO (Global Health Investment Fund & Global Health Security Fund)
Co-investorsAdBio partnersIn-Q-TelInnovation Fund sa/nvInventures Investment Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BDBugSeq BioinformaticsEUBiologicsMoxidectinPATHThemis BioscienceTransform Health FundVaxess Technologies, Inc.Verge HealthTechWomen's and Children's Health Technology Fund
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Global Health Investment Corporation made?
- Global Health Investment Corporation has 32 tracked investments, including 3 dated in the last 24 months.
- What stage does Global Health Investment Corporation invest at?
- Global Health Investment Corporation invests at the Seed, Series A, Series B stages.
- What sectors does Global Health Investment Corporation focus on?
- Global Health Investment Corporation focuses on Biotech, Digital Health, FemTech, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Corporation located?
- Global Health Investment Corporation is headquartered in New York, US.
- Who does Global Health Investment Corporation co-invest with?
- Global Health Investment Corporation most often shares deals with Ceniarth, In-Q-Tel, 8VC, among 78 tracked co-investors.
Co-investors · 3
Global Health Investment Corporation (GHIC) is a nonprofit organization that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products that improve global public health and health equity while generating sustainable financial returns.
Entrepreneur First (EF) is a talent investor that helps individuals build and launch startups, providing support such as US visa guidance, office space, fundraising preparation, and investor introductions culminating in a San Francisco Demo Day.
Adjuvant Capital is a venture capital firm that finances life science technologies addressing high-burden public health challenges, aiming to deliver both social and financial returns.
Firms observed investing alongside Global Health Investment Corporation, from public investor directories. Shared companies are the overlap with Global Health Investment Corporation's recorded portfolio.
Similar investors
Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.
Portfolia operates thematic venture funds designed by and for women investors, backing companies in women's health, active aging, and longevity, alongside a community of over 2,200 women investors across 48 states and 20 countries.
Jaza Rift Ventures is a healthcare-focused investment platform for Africa combining an investment holding company, a transaction advisory firm, and a global health innovation lab (venture studio). It backs digital health, medtech, biotech, and assistive technology founders from pre-seed to Series A.
Cross-Border Impact Ventures is an impact venture capital firm investing in health technology companies commercializing medical devices, diagnostics, therapeutics and digital health innovations focused on women, children and adolescent health.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.